Keith M. McGahan J.D., L.L.M.
Net Worth

Last updated:

What is Keith M. McGahan J.D., L.L.M. net worth?

The estimated net worth of Mr. Keith M. McGahan J.D., L.L.M. is at least $6,177,995 as of 15 Mar 2023. He has earned $282,665 from insider trading and has received compensation worth at least $5,895,330 in Spectrum Pharmaceuticals, Inc..

What is the salary of Keith M. McGahan J.D., L.L.M.?

Mr. Keith M. McGahan J.D., L.L.M. salary is $842,190 per year as Executive Vice President, Chief Legal Officer & Corporation Sec. in Spectrum Pharmaceuticals, Inc..

How old is Keith M. McGahan J.D., L.L.M.?

Mr. Keith M. McGahan J.D., L.L.M. is 49 years old, born in 1976.

What stocks does Keith M. McGahan J.D., L.L.M. currently own?

As insider, Mr. Keith M. McGahan J.D., L.L.M. owns shares in one company:

Company Title Shares Price per share Total value
Spectrum Pharmaceuticals, Inc. (SPPI) Executive Vice President, Chief Legal Officer & Corporation Sec. 189,325 $0 $0

What does Spectrum Pharmaceuticals, Inc. do?

Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor for non-small cell lung cancer tumors with various mutations; and Anti-CD20-IFNa, an antibody-interferon fusion molecule directed against CD20 that is in Phase I development for the treatment of patients with relapsed or refractory non-Hodgkin's lymphoma, including diffuse large B-cell lymphoma. It has co-development, commercialization, and in-license agreements with Hanmi Pharmaceutical Co. Ltd.; a patent and technology license agreement with The University of Texas M.D. Anderson Cancer Center; and in-license agreement with ImmunGene, Inc. The company was formerly known as NeoTherapeutics, Inc. and changed its name to Spectrum Pharmaceuticals, Inc. in December 2002. Spectrum Pharmaceuticals, Inc. was incorporated in 1987 and is based in Boston, Massachusetts.

SPPI logo
SPPI
Spectrum Pharmaceuticals, Inc.

Keith M. McGahan J.D., L.L.M. insider trading

Spectrum Pharmaceuticals, Inc.

Mr. Keith M. McGahan J.D., L.L.M. has made 43 insider trades between 2018-2023, according to the Form 4 filled with the SEC. Most recently he sold 27,197 units of SPPI stock worth $21,649 on 15 Mar 2023.

The largest trade he's ever made was exercising 41,014 units of SPPI stock on 31 Jan 2023. As of 15 Mar 2023 he still owns at least 189,325 units of SPPI stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock, $0.001 par value 27,197 $0.8 $21,649
Sale
Common Stock, $0.001 par value 15,733 $0.82 $12,885
Sale
Common Stock, $0.001 par value 18,385 $0.77 $14,156
Sale
Common Stock, $0.001 par value 11,990 $0.76 $9,124
Sale
Common Stock, $0.001 par value 41,014 $0.62 $25,429
Sale
Common Stock, $0.001 par value 26,138 $0.54 $14,219
Sale
Common Stock, $0.001 par value 16,318 $0.71 $11,521
Sale
Common Stock, $0.001 par value 14,658 $0.71 $10,334
Sale
Common Stock, $0.001 par value 15,031 $0.64 $9,620
Sale
Common Stock, $0.001 par value 13,513 $0.7 $9,500
Sale
Common Stock, $0.001 4,500 $4.16 $18,720
Sale
Common Stock, $0.001 3,735 $4.27 $15,934
Sale
Common Stock, $0.001 525 $3.07 $1,612
Sale
Common Stock, $0.001 434 $3.09 $1,339
Sale
Common Stock, $0.001 par value 2,200 $3.3 $7,260
Sale
Common Stock, $0.001 par value 1,739 $3.2 $5,565
Sale
Common Stock, $0.001 par value 16,318 $3.69 $60,213
Sale
Common Stock, $0.001 par value 14,362 N/A N/A
Sale
Common Stock, $0.001 par value 4,000 $3.73 $14,920
Sale
Common Stock, $0.001 par value 3,295 N/A N/A
Sale
Common Stock, $0.001 2,500 $3.93 $9,825
Sale
Common Stock, $0.001 1,977 $3.93 $7,770
Sale
Common Stock, $0.001 250 N/A N/A
Sale
Common Stock, $0.001 294 N/A N/A
Sale
Common Stock, $0.001 13,881 N/A N/A
Sale
Common Stock, $0.001 15,773 N/A N/A
Sale
Common Stock, $0.001 3,000 N/A N/A
Sale
Common Stock, $0.001 3,459 N/A N/A
Sale
Common Stock, $0.001 350 $3.06 $1,071
Sale
Common Stock, $0.001 400 N/A N/A
Sale
Common Stock, $0.001 1,467 N/A N/A
Sale
Common Stock, $0.001 1,786 N/A N/A
Sale
Common Stock, $0.001 2,667 N/A N/A
Sale
Common Stock, $0.001 3,341 N/A N/A
Sale
Common Stock, $0.001 1,667 N/A N/A
Sale
Common Stock, $0.001 2,020 N/A N/A
Sale
Common Stock, $0.001 294 N/A N/A
Sale
Common Stock, $0.001 3,535 N/A N/A
Sale
Common Stock, $0.001 458 N/A N/A
Sale
Common Stock, $0.001 2,018 N/A N/A
Sale
Common Stock, $0.001 1,810 N/A N/A
Sale
Common Stock, $0.001 2,496 N/A N/A
Sale
Common Stock, $0.001 437 N/A N/A

Spectrum Pharmaceuticals key executives

Spectrum Pharmaceuticals, Inc. executives and other stock owners filed with the SEC: